There appears to be too many known unknowns with MNTA at this juncture with this manufacturing issue that is beyond their control. Even the unknown unknowns is a real challenge to solve at this point.
Certainly the PPS/Market Cap reflects this today. Apropos the current management team, very disappointing to say the least. They seem as "lost' in all this drama with Sandoz/PFE as some of us investors. My biggest fear now being very transparent is if/when another company receives approval of the 40 mg dose prior to MNTA.
News 
Market Data 
Discover 
AI
